GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
7LRS | 7LRS | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7MM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MM0 | 7MM0 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MLZ | 7MLZ | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7RQ6 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual | |
7RQ6 | 7RQ6 | Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual | |
8IV8 | 8IV8 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refinement) | |
8IV8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refinement) | |
8IV5 | 8IV5 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement) | |
8IV5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement) | |
8IV4 | 8IV4 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refinement) | |
8IV4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refinement) | |
8IVA | 8IVA | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refinement) | |
8IVA | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refinement) | |
7XRP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
7XRP | 7XRP | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
7X7T | 7X7T | Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 | |
7X7T | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 | |
7WSH | A0A6J2EID0 | Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 | |
7WSH | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike receptor-binding domain in complex with sea lion ACE2 | |
8J1V | P0DTC2 | Cryo-EM structure of SARS-CoV2 Omicron BA.5 spike in complex with 8-9D Fabs | |
8J1V | 8J1V | Cryo-EM structure of SARS-CoV2 Omicron BA.5 spike in complex with 8-9D Fabs | |
7DQA | Q9BYF1 | Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex | |
7DQA | P0DTC2 | Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex | |
6XRT | Q2N0S6 | Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 | Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain |
6XRT | 6XRT | Cryo-EM structure of SHIV-elicited RHA1.V2.01 in complex with HIV-1 Env BG505 DS-SOSIP.664 | Envelope glycoprotein gp41, BG505 gp120, VRC01.23 Light chain, VRC01.23 Heavy chain |
7UR6 | C6G0D7 | Cryo-EM structure of SHIV-elicited, FP-directed Rhesus Fab RM6561.DH1021.14 in complex with stabilized HIV-1 Env Ce1176 DS-SOSIP.664 | |
7UR6 | C6G0E7 | Cryo-EM structure of SHIV-elicited, FP-directed Rhesus Fab RM6561.DH1021.14 in complex with stabilized HIV-1 Env Ce1176 DS-SOSIP.664 | |
7UR6 | 7UR6 | Cryo-EM structure of SHIV-elicited, FP-directed Rhesus Fab RM6561.DH1021.14 in complex with stabilized HIV-1 Env Ce1176 DS-SOSIP.664 | |
8DVD | A0A0C5JYT4 | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
8DVD | A0A4Y5TGK0 | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
8DVD | 8DVD | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
7KC1 | L0HR89 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | M1E1E4 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | A0A2P1E3C0 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | 7KC1 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
8JLE | Q7L0J3 | Cryo-EM structure of SV2A LD4 in complex with BoNT/A2 Hc in the SV2A-levetiracetam-BoNT/A2 Hc complex | |
8JLE | D2KCK3 | Cryo-EM structure of SV2A LD4 in complex with BoNT/A2 Hc in the SV2A-levetiracetam-BoNT/A2 Hc complex | |
8JLH | Q7L0J3 | Cryo-EM structure of SV2A dimer in complex with BoNT/A2 Hc and levetiracetam | |
8JLH | D2KCK3 | Cryo-EM structure of SV2A dimer in complex with BoNT/A2 Hc and levetiracetam | |
8JLF | Q7L0J3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8JLF | D2KCK3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8JLG | Q7L0J3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8JLG | D2KCK3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8JS9 | Q7L0J3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8JS9 | D2KCK3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc | |
8K77 | Q7L0J3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc and brivaracetam | |
8K77 | D2KCK3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc and brivaracetam | |
8JLC | Q7L0J3 | Cryo-EM structure of SV2A in complex with BoNT/A2 Hc and levetiracetam |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024